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Background: Antibiotic resistance in bacteria spreads quickly, overtaking the pace at which new compounds are
discovered and this emphasizes the immediate need to discover new compounds for control of infectious diseases.
Terrestrial bacteria have for decades been investigated as a source of bioactive compounds leading to successful
applications in pharmaceutical and biotech industries. Marine bacteria have so far not been exploited to the same
extent; however, they are believed to harbor a multitude of novel bioactive chemistry. To explore this potential,
genomes of 21 marine Alpha- and Gammaproteobacteria collected during the Galathea 3 expedition were
sequenced and mined for natural product encoding gene clusters.
Results: Independently of genome size, bacteria of all tested genera carried a large number of clusters encoding
different potential bioactivities, especially within the Vibrionaceae and Pseudoalteromonadaceae families. A very
high potential was identified in pigmented pseudoalteromonads with up to 20 clusters in a single strain, mostly
NRPSs and NRPS-PKS hybrids. Furthermore, regulatory elements in bioactivity-related pathways including chitin
metabolism, quorum sensing and iron scavenging systems were investigated both in silico and in vitro. Genes with
siderophore function were identified in 50% of the strains, however, all but one harboured the ferric-uptake-regulator
gene. Genes encoding the syntethase of acylated homoserine lactones were found in Roseobacter-clade bacteria, but
not in the Vibrionaceae strains and only in one Pseudoalteromonas strains. The understanding and manipulation of
these elements can help in the discovery and production of new compounds never identified under regular laboratory
cultivation conditions. High chitinolytic potential was demonstrated and verified for Vibrio and Pseudoalteromonas
species that commonly live in close association with eukaryotic organisms in the environment. Chitin regulation by the ChiS
histidine-kinase seems to be a general trait of the Vibrionaceae family, however it is absent in the Pseudomonadaceae.
Hence, the degree to which chitin influences secondary metabolism in marine bacteria is not known.
Conclusions: Utilizing the rapidly developing sequencing technologies and software tools in combination with
phenotypic in vitro assays, we demonstrated the high bioactive potential of marine bacteria in an efficient,
straightforward manner – an approach that will facilitate natural product discovery in the future.
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The discovery and development of new molecules for
medical treatment is in great need as the 21st century
unfolds. Drug-resistant pathogenic microorganisms are
becoming a significant threat to public health and the
pharmaceutical discovery pipelines have not been deliv-
ering the amount of new drugs required for efficient* Correspondence: henma@biosustain.dtu.dk
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unless otherwise stated.disease treatment [1-3]. Chemical synthesis has devel-
oped to be faster and cheaper as compared to biological
screenings of organisms and extracts, however, chemical
synthetic libraries have not provided the expected novel
drugs and a high percentage of new chemicals that are
introduced into the markets by pharmaceutical compan-
ies are actually derived from natural products [4]. Most
of the natural products identified are produced by non-
ribosomal peptide synthases (NRPSs) and/or polyketide
synthases (PKSs) [5,6]. NRPSs and PKSs are multifunc-
tional modular enzymes that assemble small molecules
from monomers like pearls on a string. Both enzyme typesal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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monomer, attachment to the enzyme, condensation and
chain-termination. Additionally, domains for tailoring the
monomers can be present. In case of PKSs, such as in fatty
acid synthesis, the monomers are acyl-CoAs, while NRPSs
connect naturally occurring as well as unnatural amino
acids to peptide chains. This wide range of possible sub-
units and the possibilities of their combinations lead to
the great diversity of polyketides (PKs) and non-ribosomal
peptides (NRPs) [7].
For the last century, soil microorganisms have been
isolated and screened intensively to discover novel anti-
biotics and other drugs, and, in total, microorganisms
have supplied more than 80.000 natural products [8].
Today, terrestrial Streptomyces is probably the best
exploited genus with respect to secondary metabolites
[9-13]. Streptomyces species produce a great diversity of
compounds with antifungal (nystatin, natamycin, ampho-
tericin), antibacterial (chloramphenicol, streptomycin, holo-
mycin) and antiparasitic (ivermectin) activity [14]. Also new
cultivation approaches are being used to culture new taxa,
which potentially can be a source of novel compounds, as
the recently described case of teixobactin [15].
Even though scientists have started to explore several
other habitats than the terrestrial, the marine environ-
ment stands out as a hitherto under-explored niche for
new bioactive molecules [6,16-19]. Previous studies have
indicated that since the environmental conditions are
very different from terrestrial habitats, novel compounds
and chemical classes are present, and indeed some mar-
ine natural products are characterized by the unique
marine factors such as halogenation [20-22]. Marine
natural products have been isolated and identified from
several different sources such as algae, sponges or mol-
luscs, however, several recent studies have attributed the
production of many of these compounds to microorgan-
isms associated with the eukaryotic producer previously
identified [23], bringing marine microorganisms to the
spotlight of natural product discovery.
Following the success of terrestrial streptomycetes as
producers of natural products, several researchers have
focused their search on marine actinobacteria and the
discovery of the first truly marine actinobacterium
Salinispora has provided a number of very interesting
bioactive compounds, including the anti-cancer compound
salinosporamide [24,25]. Also, subsequent mining of the
genome demonstrated an impressive number of potentially
bioactive gene clusters [16]. The Gram-negative proteobac-
teria have generally been thought to have less potential for
the production of bioactives than actinobacteria, however,
several bioactive compounds have been isolated from the
marine genus Pseudoalteromonas and more recently also
from strains of the Roseobacter clade and the Vibrionaceae
family [19,26-29].Hitherto, the vast majority of bioactive compounds have
been found using a classical bioassay-guided process,
however, this bioprospecting of drugs is expensive and
time-consuming, and re-discovery of known compounds
is, despite dereplication steps, a major challenge. The
process of drug discovery is currently undergoing changes
as a result of the rapid developments in sequencing tech-
nology and synthetic biology. The number of whole mi-
crobial genomes and metagenomic data made publicly
available is increasing exponentially and therefore, (meta)
genome mining has become an extremely attractive tool
for drug discovery [2,3,16,30,31]. It has led to the develop-
ment of new bioinformatic tools used for screening and
identification of the genetic background of the bioactiv-
ities including gene clusters responsible for the production
of the novel molecules. Many of these clusters are prob-
ably silent under most laboratory culture conditions and
require induction [32]. Several of the bioinformatic tools
have been designed to search specifically for PKS and
NRPS clusters, of which the structure is conserved. Sev-
eral recent reviews provide a comparison between differ-
ent tools, considering their modus operandi [30,31].
AntiSMASH version 2 is a strong comprehensive tool
[30] and includes the use of several of the other tools
available, such as the CLUSEAN tools [33], NRPSpredic-
tor1/2 [34,35] and a method by Minowa et al. [36]. Even
though the occurrence of misidentifications is quite
common, it is preferable to “over-identify” rather than
missing potential gene clusters [30]. Therefore, comple-
menting antiSMASH analysis with more specific tools
aids in the gene cluster identification. In this study,
we used three other tools: BAGEL3 for the identification
of bacteriocins [37]; NapDos for the identification of
keto-synthase (KS-domains) and condensation domains
(C-domains) [38]; and NP.search for the identification
of whole gene clusters that may be composed of several
KS- and/or C-domains [39]. C- and KS-domains catalyze
the chain formation of the subunits (peptides or acyl-
CoAs), respectively and a high number of these domains
reflects the richness of bonds possibly made by an organ-
ism and the degree of diversity on non-ribosomal peptide
synthesis.
The strains investigated in this genome mining study
were isolated during the Galathea 3 global expedition in
2006/7. Antagonistic activity towards the human patho-
gen Staphylococcus aureus and the fish pathogen Vibrio
anguillarum were the main selection criteria [19]. The
Galathea 3 bacterial collection has been used in previous
studies where identification of new bioactive compounds
has been successful. For instance, Photobacterium halo-
tolerans strain S2753 produces novel compound families,
the solonamides and ngercheumicins, which interfere with
virulence regulation in S. aureus [40-42]. Vibrio nigripul-
chritudo strain S2604 produces a novel siderophore:
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compounds were re-discovered, for instance, S2753
produces holomycin [28], an antibiotic previously only
isolated from terrestrial streptomycetes, and Vibrio
coralliilyticus S2052 produces andrimid [28]. Also, in
pigmented Pseudoalteromonas, we have re-identified a
range of antibiotic compounds (indolmycin, pentabro-
mopseudilin, prodigiosin) [44,45].
During the last five years, we have demonstrated that
marine Gram-negative bacteria produce an array of anti-
biotic and anti-virulence compounds [19,28,29,40,41,43-45]
and here, we ask the question if the classical biopros-
pecting approach had fully revealed the potential of
these bacteria. We present an in silico study of different
marine bacterial genomes, which were analyzed using
several of the prediction tools developed for the iden-
tification of secondary metabolism pathways, namely
antiSMASH, NapDos, Np.search, and BAGEL3 [37,46,47].










S2052 Vibrio coralliilyticus 5.4 yes 7
S2043 Vibrio coralliilyticus. 5.4 yes 7
S2604 Vibrio nigripulchritudo 6.2 yes 9
S2394 Vibrio neptunius 5.2 yes 6



















S2471 Pseudoalteromonas rubra 5.8 yes 17
S2151 Halomonas sp. 5.2 no 5
S3726 Marinomonas sp. 5.4 yes 5
S2292 Spongiobacter sp. 4.7 yes 5
S4079 Loktanella sp. 3.6 no 5
S4493 Paracoccus sp. 4.0 yes 11
S1942 Ruegeria mobilis 4.8 yes 8
F1926 Ruegeria mobilis 4.6 yes 9
DSM17395 Phaeobacter inhibens 3.8 yes 9 + 1evaluation of molecules potentially involved in production
or regulation of bioactive compounds; namely, quorum
sensing signals, siderophores and chitinases.
Results and discussion
Marine bacterial genomes – genome size
The genomes were assembled using CLC Genomics
Workbench 7 (CLC bio, Aarhus, Denmark) to obtain
contig-based draft genomes of the strains. These draft
genomes were then annotated using the Rapid Annotation
using Subsystem Technology (RAST) [48,49]. The subse-
quent analysis of the genomes was performed using CLC
Main Workbench 7 (CLC bio, Aarhus, Denmark).
The genome size varied between 3.6 and 6.2 Mb in the
21 sequenced strains (Table 1). In the six Vibrionaceae,
the genomes varied between 4 and 6.2 Mb, and the ge-
nomes of the eight Pseudoalteromonas spp. ranged from
4.1 to 6.1 Mb. The genomes of the five strains from the




KS-domains C-domains NRPS PKS Mix Trans PKS
0 3 19 1 0 1 0
2 7 13 2 0 2 0
2 7 13 2 0 2 0
0 6 17 1 0 0 0
1 4 12 1 0 1 0
0 5 0 0 0 0 0
1 8 58 7 0 1 0
1 7 30 2 0 2 0
0 5 0 0 0 0 0
0 5 0 0 0 0 0
0 5 0 0 0 0 0
1 14 48 3 0 4 1
2 12 56 3 0 2 1
0 7 0 0 0 0 0
0 6 17 2 0 0 0
1 3 3 0 0 0 0
1 3 3 0 0 0 0
1 3 2 0 0 0 0
1 4 1 0 0 0 0
0 5 1 0 0 0 0
0 4 1 1 0 0 0
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measured as zone size) [19] did not correlate to the gen-
ome size (Table 1).
It has been suggested that the potential for production
of secondary metabolites would be related to genome
size [11,50,51], with a larger genome allowing more
genes to be allocated to secondary metabolism. This no-
tion was to some extend developed by studies of the
genus Streptomyces which is a prolific producer of sec-
ondary metabolites and has relatively large genomes of
approx. 8 Mb in size as compared to other bacteria. This
understanding is changing, as the marine actinomycete
Salinispora sp. has a genome size of approx. 5 Mb, of
which approx. 10% is dedicated to secondary metabolism,
whereas only approx. 8% of the genome of Streptomyces
coelicolor has been reported as dedicated to secondary
metabolism [11,16].
Identification of gene clusters potentially encoding
secondary metabolites
The genomes were mined using bioinformatic tools for
the identification of clusters involved in secondary me-
tabolism, namely antiSMASH, NapDos, Np.search, and
BAGEL3 [37-39,47]. We found a high genetic potential
for secondary metabolite production also in Gram-negative
marine bacteria with genome sizes ranging from 4 to
6 Mb, with some strains reaching the considerable number
of eight distinct PKS/NRPS clusters (Table 1 – NP.search).
However, some strains with similar genome size harbored
none or very few potential bioactive clusters and thus,
there was no clear correlation between genome size and
number of secondary metabolism gene clusters. Some
strains, such as V. nigripulchritudo S2604 or Halomonas
sp. S2151, with larger genomes had a low number of hits;
and also contrarily, strains with smaller genomes had a
greater number of hits e.g. P. piscicida strains S2040 and
S2724 (Table 1).
Bioactivity potential - NRPS/PKS
The presence of gene clusters likely encoding bioactive
compounds is spread among the different families of
Alpha- and Gammaproteobacteria. Although our collec-
tion is limited in number, it appears that the Gamma-
proteobacteria class is richer in NRPS and PKS clusters
than the Alphaproteobacteria. The analysis using NapDos
and NP.search, in general, identified the same number of
potential bioactive gene clusters. A higher frequency of
KS- and C-domains was identified in pigmented Pseudoal-
teromonas strains (S2040; S2724; S4054; S2471) followed
by Vibrionaceae, with the exception of S2757 (no hits),
and Marinomonas sp. S3726 (high number of hits).
Some species in the Rhodobactereaceae family (Ruegeria
mobilis and Phaeobacter inhibens) are capable of inhibit-
ing a wide range of other bacteria [52-54]; however, ingeneral, few secondary metabolites have been identified
in these strains [54-57]. Here, we show that using bio-
informatics tools a few clusters could be identified, but
still the bioactive potential harbored in the genome of
these genera appears much lower than that observed in
Gammaproteobacteria.
A number of strains that were not antagonistic in
agar-based assays were included in the analysis and these
contained only few gene clusters potentially coding for
secondary metabolites (Table 1). This was the case for
Vibrio sp. S2757 and P. agarivorans S816, for which anti-
SMASH identified only two potential clusters (Table 1).
Another interesting group of strains included those
that received five hits in total in the antiSMASH analysis.
This includes the bioactives Marinomonas sp. S3726 and
Spongiobacter sp. S2292 and the non-bioactives Halomo-
nas sp. S2151 and Loktanella sp. S4079. Although, all of
them had a considerably lower number of hits in the anti-
SMASH analysis than the pigmented pseudoalteromo-
nads and the vibrios, the results of the other mining tools
(NaPDoS) demonstrate that Marinomonas sp. S3726 has a
great potential with 6 KS- and 17 C-domains identified
(Table 1). Thus, the sole number obtained by one given
analysis tool may not reflect the whole potential of the or-
ganism, and complementary analysis should be performed
to ensure discovery of the full bioactive potential. This
should also be done to avoid further work on clusters that
may not be true secondary metabolite clusters, it appears
from the analysis that NapDos and NP.search tools
seemed to identify only a subset of the NRPS/PKS clusters
identified by antiSMASH.
The potential for secondary metabolite production in
the strains is clearly much larger than so far identified by
bioassay-guided fractionation. For instance, the PK/NRP
hybrid andrimid has been identified as the bioactive com-
pound in V. coralliilyticus S2052 [28,29,58,59]. The gen-
ome mining identified the gene cluster likely encoding for
andrimid production genes (Figure 1(A)). Also, we found
at least three more NRPS clusters using antiSMASH, Nap-
Dos and NP.search (Table 1). Similarly, in P. halotolerans
S2753, the dithiolopyrrolone holomycin was identified in
extracts [28] and the corresponding gene cluster was
found by the bioinformatic tools used (Figure 1(B)); again,
four more NRPS/PKS clusters were found using anti-
SMASH, although only one more was discovered when
using NP.search (Table 1). As indicated, we and others
have identified several bioactive compounds from pigmen-
ted pseudoalteromonads and here we also identified the
respective gene clusters for indolmycin [44], violacein [60]
and pentabromopseudilin [5,61,62]. However, the pig-
mented pseudoalteromonads contained a large number of
potential bioactive clusters, including a very high number
of C-domains as compared to the other studied strains
(NapDos – Table 1).
Figure 1 Previously known clusters identified in the studied marine bacteria, using genome mining. Andrimid gene cluster from V. coralliilyticus
S2052 (A); Holomycin gene cluster from P. halotolerans S2753 (B).
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In in vitro assays, Pseudoalteromonas ruthenica is highly
antagonistic against S. aureus and V. anguillarum caus-
ing large clearing zones in agar-based screening assays
[19]. However, we have not been able to identify the
compound(s) responsible for this inhibition by bioassay-
guided fractionation and anticipated that genome mining
would reveal potential bioactive gene clusters. Anti-
SMASH identified three gene clusters (one for sidero-
phore and two for bacteriocin biosynthesis), but only
the siderophore cluster was correctly identified, whereas
the bacteriocin-related clusters were misidentified and
encoded the flagella operon and a cluster encoding for
hypothetical proteins, a muramoyltetrapeptide carboxy-
peptidase and a 2,3,4,5-tetrahydropyridine-2,6-dicarboxy-
late N-succinyltransferase, involved in the biosynthesis of
peptidoglycan and lysine, respectively.
A second analysis of the P. ruthenica strains with anti-
SMASH based on PFAM domain probabilities increased
the number of potential gene clusters from three to thir-
teen. Mainly clusters encoding for acyl carrier proteins
were identified, but we also identified some biosynthetic
clusters such as lipopolysaccharide, capsular polysac-
charide, legionaminic acid and fatty acid biosynthesis.
From all the clusters, only one matched with the RAST
annotation as behaving an open reading frame (ORF)
encoding a non-ribosomal peptide synthase. Yet this
ORF was only 663 bp, and when we blasted the pre-
dicted aminoacid sequence against the NCBI protein
database, it presented a high similarity with a methionyl-
tRNA formyltransferase and not to an NRPS. In agree-
ment with these were NapDos and NP.search, which did
not identify any potential bioactive clusters (Table 1).
This reduces the likelihood that the clusters identified
by antiSMASH using PFAM domains are actually clusters
responsible for the production of bioactives.
In genome mining, the identification of clusters likely
involved in secondary metabolism, such as NRPS and
PKS, have been used as a measure of the potential forfinding novel natural bioactive compounds, including
antibiotics [63]. Yet, all the bioinformatic tools used to
search for the biosynthetic capabilities and potential of
P. ruthenica failed. This might be the case because the
antagonistic activity is due to other biosynthetic path-
ways as is for instance the case with the antibiotic tro-
podithietic acid produced by some Roseobacter clade
bacteria [64]. Also, it can be attributed to limitations in
the prediction algorithms. The prediction algorithms of
the bioinformatic tools are to some extend based on
identification of known biosynthetic activities and one
could speculate that truly novel biosynthetic pathways
would not be identified. To identify the core genes of a
biosynthetic pathway, most of the tools available use
profile-HMMs or alignments of conserved domains in
biosynthetic enzymes [30]. This is a problem in the iden-
tification of non-standard pathways and antiSMASH has
therefore implemented an algorithm to identify the dis-
tribution of protein domains usually associated with sec-
ondary metabolites [30], increasing the probability of
identification of clusters responsible for secondary me-
tabolites production. This not only increases the number
of hits, but also the time needed for evaluation of the
clusters, raising the question of the feasibility of using
genome mining in groundbreaking discoveries.
Bacteriocins
The number of clusters identified by antiSMASH as bac-
teriocins varied between one and five in each strain, with
an average of two clusters per strain. However, when the
genomes were analyzed using the prediction tool
BAGEL3 [37], the presence of bacteriocin-related genes
was only confirmed in a few strains. The distribution of
bacteriocin clusters did not follow a particular pattern
with respect to genera or species.
It seems evident that the specific prediction tools are
more accurate in identifying their defined target; therefore,
BAGEL 3 being most probably a better indicator of
the number of bacteriocin-related genes than antiSMASH
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case, where random genes were classified as bacteriocins
(see above).
Acyl homoserine lactones
Four of the 21 strains induced a clear response in the
AHL (acyl homoserine lactone) biomonitors (Table 2).
Three strains, Vibrio sp. S2757, Paracoccus sp. S4493
and P. luteoviolaceae 4054 induced both monitors whereas
P. inhibens DSM17395 induced only A. tumefaciens. This
is in agreement with previous studies where also Phaeo-
bacter sp. strain S27-4 induced A. tumefaciens and chem-
ical analysis identified 3-hydroxy-decanoyl-homoserine
lactone [64]. Interestingly, antiSMASH detected homoser-
ine lactone synthases in three of these four strains but not
in Vibrio S2757. The response in the monitor strains could
be caused by other compounds, such as diketopiperazines
that have been demonstrated to induce the AHL
monitors [65]. The same could be true for the extracts of
the V. coralliilyticus strains S2052 and S2043, which resul-
ted in a weak reaction in C. violaceum, and the genomes
did not contain an AHL synthase gene. AntiSMASHTable 2 Iron system in the studied strains, comprising in silico
Strain Species Response in AHL monito
Cv At
S2753 Photobacterium halotolerans - -
S2052 Vibrio coralliilyticus (+) -
S2043 Vibrio coralliilyticus (+) -
S2604 Vibrio nigripulchritudo - -
S2394 Vibrio neptunius - -
S2757 Vibrio sp. + +
S2040 Pseudoalteromonas piscicida - -
S2724 Pseudoalteromonas piscicida - -
S816 Pseudoalteromonas agarivorans - -
S3258 Pseudoalteromonas ruthenica - -
S3137 Pseudoalteromonas ruthenica - -
S4054 Pseudoaltermonas luteoviolacea + +
S2471 Pseudoalteromonas rubra - -
S2151 Halomonas sp. - -
S3726 Marinomonas sp. - -
S2292 Spongiobacter sp. - -
S4079 Loktanella sp. - -
S4493 Paracoccus sp. + +
S1942 Ruegeria mobilis - -
F1926 Ruegeria mobilis - -
DSM17395 Phaeobacter inhibens - +
Cv: Chromobacterium violaceum, At: Agrobacterium tumefaciens, HSL: homoserine lacto
bioactivity detected under the tested conditions, NRPS: including single NRPS clusters
plasmid; **Cluster identified as a siderophore – ectoine cluster; ***At least one NRPS isdetected AHL synthase genes in three strains (Loktanella
sp. and two Ruegeria mobilis) where no AHLs were de-
tected by the monitors (Table 2). These genes could po-
tentially encode novel AHLs not being in the detection
range of the used biological monitors [66]. On the other
hand, the bacteria may not have been cultured under con-
ditions allowing the expression of the presumed AHL syn-
thase genes or the AHL concentration produced was
below the detection limit. We considered if the potential
QS systems could be involved in production of secondary
metabolites. In P. luteoviolaceae, the AHL synthase gene
is adjacent to the gene cluster potentially involved in
indolmycin production [67], but in the other five strains
the HSL synthase genes detected by antiSMASH were
not in proximity to identified natural product gene clus-
ters. However, some were close to genes encoding acyl
synthases, alcohol dehydrogenases or proteins contain-
ing AMP-binding domains, which may potentially be in-
volved in secondary metabolism. Due to draft genomes
with multiple contigs, the association with natural prod-






0 + 1 4 1
0 - 1** 4*** 1
0 (+) 1** 4*** 1
0 - 0 4*** 1
0 (+) 1 3*** 1
0 + 1** 0 1
0 + 0 11*** 1
0 + 0 5*** 1
0 + 1 0 1
0 + 1 0 1
0 - 1 0 1
1 (+) 0 11*** 1
0 (+) 0 9*** 1
0 (+) 1 0 1
0 + 0 3*** 1
0 - 0 1 1
1 (+) 0 1*** 1
4 - 0 2 0
2 (+) 0 1*** 1
2 (+) 0 1*** 1
2 + 1* 1 1
ne, CAS: chrome-azurol-S, + : strong bioactivity, (+) : weak bioactivity, − : no
and NRPS fusion clusters (e.g. NRPS-bacteriocin, NRPS-ectoine). *Located on a
in proximity to siderophore-associated genes (tonB-dependent receptor etc.).
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Iron is essential for almost all microorganisms being
required for key biological processes [68] and is also one of
the most important requirements for successful secondary
metabolism. The iron levels in seawater are extremely low,
and many marine bacteria are able to sequester iron using
siderophores that can also serve as a tool in microbial com-
petition. Hence, siderophores are included as secondary
metabolites in the antiSMASH search.
To complement the genetic search, we determined sidero-
phore activity using the CAS assay [69]. Pronounced sidero-
phore activity was detected in eight strains and a weak
reaction was observed in eight further strains. Only five strains
did not show any activity under the tested conditions (Table 2).
The NRPS prediction tools, NapDos and NP.search, do not
allow detailed prediction of the type of NRPS coding gene,
however, antiSMASH is able to distinguish siderophore syn-
thesis genes. The in silico analysis using antiSMASH identified
putative siderophore gene clusters in five of the eight strains
with a clear CAS reaction, and three of the eight with a weak
reaction. In one strain, P. ruthenica, antiSMASH detected
a siderophore synthesis gene, but the CAS assay was nega-
tive. In contrast, the CAS reaction was positive for three
strains (two P. piscicida and one Marinomonas) where a
siderophore biosynthesis gene was not detected. Anti-
SMASH predicts siderophore genes using the currently
available sequence information on siderophore-producing
NRPSs, which are mainly of terrestrial origin. Terrestrial
siderophores differ structurally from marine siderophores
that are usually associated with fatty acids [68]. We ana-
lysed the identified NRPS gene clusters for siderophore-
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MSDNNQA - - - - - L KD AG L K V T L PR L K I L E V L QQP ECQH - I S AE E L YK K L I D L GE E I GL A T V YR V L NQ F DD AG I V TR
MSDNNQA - - - - - L KD AG L K V T L PR L K I L E V L QQP ECQH - I S AE E L YK K L I D L GE E I GL A T V YR V L NQ F DD AG I V TR
MPDNNQA - - - - - L K E AG L K V T L PR L K I L E V L QQPDC SH - I S AE E L YK K L I D L GE E I GL A T V YR V L NQ F DD AG I V TR
MSDNNQA - - - - - L KQAG L K V T L PR L K I L E V L QN P ECQH - I S AED L YK K L I D I GE E I GL A T V YR V L NQ F DD AG I V TR
MAD KNH E - - - - - L R K AG L K V T L PR VK I L Q I L E S A T DQHH L S AED V YK T L L E AGED VGL A T V YR V L TQ F E S AG L V I R
MT S ENQE - - - - - L K K AG L K V T L PR VK I L Q I L E S AGERH - M S ADD V YR T L L EQGED VGL A T V YR V L TQ F EN AG L V VR
MT P T H E EN AN KWL ME AG L R P T RQR V T L A A L L VGDGQHRH V T AE S L FD A AK DDG A A VS L A T V YN T L R A F CD AG V L QE
MT P T H E EN AN KWL ME AG L R P T RQR V T L A A L L VGDGQHRH V T AE S L FD A AK DDG A A VS L A T V YN T L R A F CD AG V L QE
MT P T P AD I A T NWL E T AG L R P T RQR V A L AE L L VGDGKHRH V T AE S L FD A AK D KG A A VS L A T V YN T L R A F CD AG V L QE
MTD I V T QR S S DWL SGAG L R P T RQRMT L AS L L VGDGQDRH V T AE S L FD A AS S AGE K VS L A T V YN T L R A F CD AG L MR E
GGK S V F E L SG S T HHDH L VC L KCGK V VE F ED D V I E T RQE E I AN SNG I K L T N H S L Y L YGEC E D K E AC K K Y AE ENG - - -
GGK S V F E L SG S T HHDH L VC L KCGK V VE F ED D V I E T RQE E I AN SNG I K L T N H S L Y L YGEC E D K E AC K K Y AE ENG - - -
GGK S V F E L SG S T HHDH L VC L KCGK V VE F ED D L I ERRQL E I AE ENG I T L T N H S L Y L YGECQ D K A AC K A F SD SN - - - -
GGK S V F E L SG S T HHDH L VC L KCGK V VE F ED DM I ERRQL E I AE ENG I T L T N H S L Y L YGECN D K A AC K E F SD AN - - - -
GGK S V F E L SG S T HHDH L VC L KCGK V I E F ED E L I ERRQE E I AK ENG I K L T N H S L Y L YGECN D E E AC KN YGD E - - - - -
GGK S V F E L SG S T HHDH L VC L KCGK V I E F ED E V I E T RQVE I A T SNG I K L T N H S L Y L YGEC V D E E ECRR F T E SD E - - -
GGK S V F E L AG S T HHDH L VC L KCGR V I E F ED DM I ERRQVE I AE ENG I T L T N H S L Y L YGEC K D VE AC KN Y AE MSN - - -
GGK S V F E L AG S T HHDH L VC L KCGR V I E F ED DM I ERRQVE I AE ENG I T L T N H S L Y L YGEC K D VE AC KN Y AE MSN - - -
GGK S V F E L S T QHHHDH L VC L DCGE V I E F AD D I I E ERQK E I ASQYN V I L T N H S L Y L YGKC A D - GSCRDN PD AH K - K K
GGK S V F E L S T QHHHDH L VC L DCGE V I E F AD D I I E ERQK E I ASQYN V I L T N H S L Y L YGKC A D - GSCRDN PD AH K - K K
GGK S V F E L S T QHHHDH L VC L DCGE V I E F AD D I I E ERQK E I AKQYN V I L T N H S L Y L YGKC A D - GSCRDN PD AH K L K K
GGK S V F E L S T QHHHDH L VC L DCGE V I E F SD D V I E ERQK E I AE K YN V I L T N H S L Y L YGKCG D - GSC KHN PD AH K P K S
GGK S V F E L S T QHHHDH L VC L DCGE V I E F SD E V I E ERQR E I A AK YN VE L T N H S L Y L YGKCG D - R SC KDD PN AH K P K K
GGK S V F E L S T QHHHDH L VC L DCGK V I E F SD D L I E ERQKQ I AE S YN I R L T N H S L Y L YGHC T A - GDCN KD E S L HN E K K
GGH A V F E L SQ E EHHDHMVC L E SGE I I E F F D E T I ERRQQE I AE EHG F E L VD H A L V L Y VR P K GS K A T RQEG I AK K - - -
AGT A V F E I AK GEHHDHMVCM D SGK V I E F YD P I I E KRQK E I A AEHG YE I ED HN L V L Y VR P K D - - - - - - - - - - - - - - -
GS K S Y F D - T N VHDH PH Y YWE GEGR VSD AP S E E L V I QS L PQ P P E - GME I AS VD V V I - - - - - - - - R L R K K AE L S - - - -
GS K S Y F D - T N VHDH PH Y YWE GEGR VSD AP S E E L V I QS L PQ P P E - GME I AS VD V V I - - - - - - - - R L R K K AE L S - - - -
GS K S Y F D - T N THDH PH F YWE D EGR L SD AP S DQL V I K S L P A APQ - G VE I AS VD V V I - - - - - - - - R L R K - - - - - - - - -
GAK S Y F D - T N MT DH PH F YWE D T AH L T D AP A EQL E I AR VPH AP E - G AE I AS VD V V I - - - - - - - - R L RR K - - - - - - - -
A
Figure 2 Analysis of the Fur sequences of the marine bacterial strains
neighbor joining tree using Jukes-Cantor protein distance measurement mFor twelve strains, these siderophore-associated genes
were found close to the NRPS gene leading to the hy-
pothesis that this NRPS gene could likely encode a
siderophore-producing NRPS. This would demonstrate
that all strains based on their genetic information
would be capable of scavenging iron using siderophores.
To detect this “hidden” activity for the five non-active
strains, the strains might require optimization of culture
conditions or certain biological cues from the environ-
ment. Iron can also be scavenged by other molecules and
non-siderophore iron sequestering systems may be oper-
ational in the bacteria where siderophore genes were not
detected. Indeed, several heme-related proteins were
identified among the studied marine bacteria by an
annotation-based search (data not shown).
Even though iron is essential for growth, excess of iron
can be toxic to bacteria and thus a tight regulation of up-
take is crucial for microbial survival [68]. In Gram-negative
bacteria, iron regulation is achieved by a repressor protein
named Fur (Ferric-iron uptake regulator) which acts at the
transcriptional level [70]. A Fur encoding gene could be
identified in all the studied strains and the amino acid
sequence predicted, with the sole exception of Paracoccus
sp. S4493 (Table 2; Figure 2(A)). The verified exception of
Paracoccus sp. S4493 might be due to sequencing limita-
tions, or the fact that this organism has another regu-
latory protein involved in iron sensing; in fact other
uptake regulators for different metals could be identified
(e.g. manganese, potassium, zinc, and nickel).
Within the classes of Proteobacteria, the Fur proteins
are relatively conserved at the amino acid level, presenting





















































































used. Predicted Fur protein sequence alignment (A); Phylogenetic
ethod (B).
Table 3 Chitinolytic systems in the studied strains,







+++ 3 1 1
S2052 Vibrio coralliilyticus ++ 9 1 2
S2043 Vibrio coralliilyticus ++ 9 1 2
S2604 Vibrio nigripulchritudo + 8 2 0
S2394 Vibrio neptunius ++ 7 1 0
S2757 Vibrio sp. ++ 3 1 1
S2040 Pseudoalteromonas
piscicida
++ 4 1 0
S2724 Pseudoalteromonas
piscicida
+++ 4 0 0
S816 Pseudoalteromonas
agarivorans
- 0 0 0
S3258 Pseudoalteromonas
ruthenica
++ 3 0 1
S3137 Pseudoalteromonas
ruthenica
++ 3 0 1
S4054 Pseudoaltermonas
luteoviolacea
+ 10 0 0
S2471 Pseudoalteromonas
rubra
+ 7 0 0
S2151 Halomonas sp. - 0 0 0
S3726 Marinomonas sp. - 0 0 0
S2292 Spongiobacter sp. - 0 0 1
S4079 Loktanella sp. - 0 0 0
S4493 Paracoccus sp. - 0 0 0
S1942 Ruegeria mobilis - 0 1 0
F1926 Ruegeria mobilis - 0 1 0
DSM17395 Phaeobacter inhibens - 0 0 0
ChiS: chitin catabolic cascade sensor histidine kinase, CBP: chitin binding proteins.
- : no chitinase activity detected, + : low chitinase activity, ++ : medium chitinase
activity, +++ : strong chitinase activity.
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binding-α-helix and Fe2+ and Zn2+ binding domains
could be identified [71]. A neighbor joining tree using
Jukes-Cantor protein distance measurement method
(Figure 2(B)) demonstrates the conservation of closely
related species, indicating that the fur gene is a phylogenetic
trait instead of a random species variation or a product of
recent horizontal gene transfer. In fact, the clusters based
on protein sequences follow the phylogenetic distribution;
the analyzed Alphaproteobacteria sequences form a separ-
ate, distant group from the families of Gammaproteobac-
teria, in which the Pseudoalteromonadaceae and the
Vibrionaceae families form two distinct clusters from the
other Gammaproteobacteria. The only exception here was
the Spongiobacter sp. S2292, which clustered together with
the Pseudoalteromonas spp. This is interesting, since the
16S rRNA sequence (GenBank acc. no. FJ457273.1) would
place Spongiobacter sp. S2292 closer to the Endozoicomonas
genus and therefore within the order of Oceanopirillales, in
which the species Halomonas andMarinomonas are also in-
cluded [72]. This fact brings to question the phylogenetic
placement of Spongiobacter as it remains an unclassified
member of Gammaproteobacteria, and this association indi-
cates a closer association with Pseudoalteromonas species
than with the other Gammaproteobacteria.
Interestingly, this clustering seems to be specific at
species level, even for the Vibrio strains studied. Identify-
ing Vibrio strains to species level typically requires multi-
locus sequence analysis [73,74]. We recently showed that
the fur gene is a good phylogenetic marker (Machado &
Gram, submitted) to be added to the multilocus sequen-
cing analysis performed nowadays in e.g. Vibrio species
definition [73-75] and might also be possibly used in other
genera for species differentiation.
Chitinases and regulation
Chitin is ─ after cellulose ─ the most abundant carbon
source on Earth. Enzymes capable of degrading this
organic compound are very useful in biotechnological
industries. At the same time, chitin is also an important
environmental clue influencing regulators of virulence
and secondary metabolism [58,76-78]. We have previously
shown that an andrimid producing V. coralliilyticus S2052
focuses its secondary metabolism exclusively on andrimid
when grown on chitin as compared to growth on glu-
cose and casamino acids [58]. This could be coupled
with transcriptional changes and we therefore also mined
the genomes for chitin catabolic cascade sensor histidine
kinase (ChiS) and chitin binding proteins (CBP).
By phenotypic assays, we identified several strongly
chitinolytic strains and screened their genomes for chitinase
encoding genes. All of the Vibrionaceae and pigmented
Pseudoalteromonas sp., with the exception of P. agarivorans
S816, were capable of degrading chitin (Table 3). Thegenome mining revealed presence of three to nine chitinase
encoding genes per strain in the chitinolytic bacteria.
Chitin-related genes were present in Vibrio species,
which is likely related to their ecology and close association
with crustaceans [79,80]. The pigmented pseudoalteromo-
nads are also often associated with eukaryotic surfaces [44]
including organisms containing no chitin. However, several
pseudoalteromonads had genes encoding for chitinases
and showed prominent chitinolytic activity.
The chitinolytic cascade has previously been studied in
Vibrio species where its tight regulation was attributed
to the hybrid chitin catabolic sensor/kinase (ChiS) to-
gether with a periplasmic chitin oligosaccharide binding
protein (CBP) [77]. This regulatory system has been
shown to regulate expression of 50 genes, most of which
involved in chitin catabolism [77]. Furthermore, it has
Machado et al. BMC Genomics  (2015) 16:158 Page 9 of 12been also shown that natural substrates such as chitin in-
fluence secondary metabolite production, such as the in-
duction of their production [58]. We searched for the chiS
gene, which was present in all of the six Vibrionaceae, one
Pseudoalteromonas, and two Ruegeria (Table 3). The
Alphaproteobacteria did not degrade chitin, though two
Ruegeria mobilis strains harbor the chitin sensor genes.
Interestingly, the ChiS regulator was only present in
the Vibrio strains, suggesting that transcriptional shaping
by chitin could be a trait associated with this family.
Changes in secondary metabolism by chitin and the
presence of the regulator ChiS requires further studies
for confirmation.
Conclusions
Here, we presented a straightforward, comprehensive gen-
ome mining approach analyzing marine bacterial strains
for secondary metabolism and associated features such as
quorum-sensing, iron acquisition, chitin use as a carbon
source and its regulation. The use of complementary tools
for genome mining is of great value in narrowing down
the potential gene clusters from a large pool obtained by
broad prediction software such as antiSMASH. We dem-
onstrated the great potential of marine bacteria for sec-
ondary metabolite production, with special focus on
Vibrio and pigmented Pseudoalteromonas species.
Methods
Bacterial strains and growth conditions
Bacterial strains used in this study were isolated during
the Danish Galathea 3 global research expedition (http://
www.galathea3.dk/uk) [19] and selected due to their
antagonistic activity against a Gram-negative (Vibrio angu-
illarum) and a Gram-positive (Staphylococcus aureus)
pathogenic bacterium. Pure cultures of each strain were
stored in cryoprotectant solution at −80°C from their
isolation until the present study. Phaeobacter inhibens
DSM17395 was obtained from the German Collection of
Microorganisms and Cell Cultures (DSMZ, Germany).
Some of the strains have previously been used in classical
bioassay-guided bioprospecting and produce antibiotics or
anti-virulence compounds [19,22,27-29,40-45,58]. Strains
were routinely grown on Marine Agar (Difco 2216) and in
Marine Broth (Difco 2216).
Genomic DNA isolation and Sequencing
High purity genomic DNA was extracted by succes-
sive phenol:chloroform:isoamyl-alcohol purification steps
followed by precipitation with isopropanol, treatment with
RNase and a final purification and precipitation step [81].
Quantification was done in 1% agarose gel electrophoresis,
NanoDrop Spectrometer (Saveen Werner, Sweden) and
Qubit 2.0 Analyser (Invitrogen, United Kingdom). Se-
quencing of the genomes was performed by BeijingGenomic Institute (Shenzhen, China). Libraries of 500 bp
were used for 100 bp paired-end sequencing of genomes
using the Illumina sequencing technology on a HiSeq2000
with a minimum coverage of 100. Genomic DNA se-
quences were assembled in contigs using CLC Gen-
omic Workbench (CLC Bio, Aarhus, Denmark). All
the genomes had a coverage of 75x or higher. All of
them were submitted to the National Center for Biotech-
nology Information (NCBI) database under the accession
numbers AUXW00000000, JMIB00000000, APME000000
00, AQCH00000000, CP002972, CP002973, CP002974,
CP002975, JXXR00000000, JXXS00000000, JXXT000
00000, JXXU00000000, JXXV00000000, JXXW00000
000, JXXX00000000, JXXY00000000, JXXZ00000000,
JXYA00000000, JXYB00000000, JXYC00000000, JXYD0
0000000, JXYE00000000, JXYF00000000, JXYG00000000.
Bioinformatic analysis
The draft genomes were annotated using RAST [49] and
submitted to secondary metabolite gene cluster analysis
using antiSMASH 2.0 [47], NapDos [38], NP.search [39],
as well as to the bacteriocin-specific software BAGEL 3
[37]. Following RAST annotation, a homology search
was conducted on the ferric-iron uptake regulator gene
fur and an annotation-based search was performed for
genes encoding, chitinases and the chitin catabolic cas-
cade sensor gene chiS.
Verification of antibacterial activity
The strains were re-tested for their antibacterial activity,
as previously described [19]. Briefly, strains to be tested
were grown in Marine Agar (Difco 2216) for 24 – 48 h
and one colony was spotted in plates of artificial seawater
agar with 3% Instant Ocean (IO; Aquarium Systems Inc.,
Sarrebourg, France) containing Vibrio anguillarum strain
90-11-287 serotype O1 [82] or Staphylococcus aureus
strain 8325 [83] embedded. The plates were incubated
and observed for clearing zones in the agar.
Production of acyl homoserine lactones
Production of acyl homoserine lactone (AHL) com-
pounds was analysed using two AHL monitor systems
Agrobacterium tumefaciens NT1(pZLR4) [84] and Chro-
mobacterium violaceum CV026 [85] as described by
Ravn et al. [86]. The strains were grown in 10 mL
½YTSS or sea salt medium (1.5% sea salt, 0.3% casamino
acids, 0.4% glucose) in 50 mL Falcon tubes for 48 hours
at 200 rpm and room temperature and extracted with
10 mL ethyl acetate acidified with 1% formic acid. The
extract was dried under nitrogen, resuspended in 0.5 mL
ethyl acetate containing 1% formic acid and stored
at −20°C. The extracts were tested with the AHL-reporter
strains in a plate well assay [87].
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Siderophore activity was tested using the liquid CAS
assay [69]. The marine strains were grown in 10 mL sea
salt medium or ½YTSS in 50 mL Falcon tubes at 25°C
and 200 rpm for 24 and 48 hours at room temperature.
1 mL of culture was centrifuged for 5 min at 12,100 × g
and the supernatant was mixed with CAS solution in a
1:1 ratio. Colour change from blue to orange indicating
siderophore activity was observed after 5 min and 24 h.
Chitinase activity
Chitinase activity was tested on chitin containing agar
plates. Strains were grown on Marine Agar (Difco 2216)
for 24 – 48 h and one colony was spotted on plates con-
taining 20 g/L sea salts, 3 g/L casamino acids, 0.08% hy-
drolyzed chitin, 20 g/L agar. The plates were incubated
for 72 h and chitinase activity monitored at 24, 48 and
72 h. The natural turbidity of the media due to chitin al-
lows the visual evaluation of chitin degradation, which
leads to clearance of the media. Chitinase activity was
graded qualitatively: low chitinase activity (<1.0 mm)
zones were scored with one plus, medium chitinase
activity zones (1.0 mm – 3.0 mm) with two pluses, and
strong chitinase activity (>3.0 mm) with three plusses.
Abbreviations
NRPS: Non-ribosomal peptide synthase; PKS: Polyketide synthase;
KS-domains: Keto-synthase domains; C-domains: Condensation domains;
RAST: Rapid Annotation using Subsystem Technology; PFAM: Protein families
database; ORF: Open reading frame; profile-HMMs: Profile hidden Markov
models; AHL: Acyl homoserine lactone; QS: Quorum sensing; HSL: Homoserine
lactone; CAS: Chrome azurol S; Fur: Ferric-iron uptake regulator; ChiS: Chitin
catabolic cascade sensor histidine kinase; CBP: Chitin binding protein.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HM and LG designed the study and HM, ESC and JM carried out the
experiments. All authors contributed to the writing of the manuscript.
All authors read and approved the final manuscript.
Acknowledgments
HM was supported by a PhD grant from the People Programme
(Marie Curie Actions) of the European Union’s Seventh Framework
Programme FP7-People-2012-ITN, under grant agreement No. 317058,
“BACTORY”. ECS was supported by the European Union’s Seventh Framework
Programmes KBBE-2012-6-311975 MaCuMBA (Marine Microorganisms:
Cultivation Methods for Improving their Biotechnological Applications) and
KBBE-2012-6-312184 PharmaSea (Increasing Value and Flow in the Marine
Biodiscovery Pipeline). The present work was carried out as part of the
Galathea 3 expedition under the auspices of the Danish Expedition
Foundation. This is Galathea 3 contribution no. p110.
Received: 16 January 2015 Accepted: 20 February 2015
References
1. Xu J, Hagler A. Chemoinformatics and drug discovery. Molecules.
2002;7:566–600.
2. Scheffler RJ, Colmer S, Tynan H, Demain AL, Gullo VP. Antimicrobials, drug
discovery, and genome mining. Appl Microbiol Biotechnol. 2013;97:969–78.
3. Zerikly M, Challis GL. Strategies for the discovery of new natural products by
genome mining. Chembiochem. 2009;10:625–33.4. Newman DJ, Cragg GM. Natural products as sources of new drugs over the
last 25 years. J Nat Prod. 2007;70:461–77.
5. Moore BS. Biosynthesis of marine natural products: microorganisms (Part A).
Nat Prod Rep. 2005;22:580–93.
6. Xiong Z-Q, Wang J-F, Hao Y-Y, Wang Y. Recent advances in the discovery
and development of marine microbial natural products. Mar Drugs.
2013;11:700–17.
7. Meier JL, Burkart MD. The chemical biology of modular biosynthetic
enzymes. Chem Soc Rev. 2009;38:2012–45.
8. Bérdy J. Thoughts and facts about antibiotics: where we are now and
where we are heading. J Antibiot. 2012;65:441–41.
9. Yu D, Xu F, Valiente J, Wang S, Zhan J. An indigoidine biosynthetic gene
cluster from Streptomyces chromofuscus ATCC 49982 contains an unusual
IndB homologue. J Ind Microbiol Biotechnol. 2013;40:159–68.
10. Li B, Walsh CT. Identification of the gene cluster for the dithiolopyrrolone
antibiotic holomycin in Streptomyces clavuligerus. Proc Natl Acad Sci U S A.
2010;107:19731–5.
11. Udwary DW, Zeigler L, Asolkar RN, Singan V, Lapidus A, Fenical W, et al.
Genome sequencing reveals complex secondary metabolome in the
marine actinomycete Salinispora tropica. Proc Natl Acad Sci U S A.
2007;104:10376–81.
12. Yin H, Xiang S, Zheng J, Fan K, Yu T, Yang X, et al. Induction of holomycin
production and complex metabolic changes by the argR mutation in
Streptomyces clavuligerus NP1. Appl Environ Microbiol. 2012;78:3431–41.
13. Li B, Walsh CT. Streptomyces clavuligerus HlmI is an intramolecular
disulfide-forming dithiol oxidase in holomycin biosynthesis. Biochemistry.
2011;50:4615–22.
14. Bhattacharya D, Nagpure A, Gupta RK. Bacterial chitinases: properties and
potential. Crit Rev Biotechnol. 2007;27:21–8.
15. Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, et al. A
new antibiotic kills pathogens without detectable resistance. Nature.
2015;517:455–9.
16. Ziemert N, Lechner A, Wietz M, Millán-Aguiñaga N, Chavarria KL, Jensen PR.
Diversity and evolution of secondary metabolism in the marine
actinomycete genus Salinispora. Proc Natl Acad Sci U S A. 2014;111:E1130–9.
17. Zhao X-Q. Genome-based studies of marine microorganisms to maximize
the diversity of natural products discovery for medical treatments. Evid
Based Complement Alternat Med. 2011;2011:384572.
18. Wietz M, Duncan K, Patin NV, Jensen PR. Antagonistic interactions
mediated by marine bacteria: the role of small molecules. J Chem Ecol.
2013;39:879–91.
19. Gram L, Melchiorsen J, Bruhn JB. Antibacterial activity of marine culturable
bacteria collected from a global sampling of ocean surface waters and
surface swabs of marine organisms. Mar Biotechnol (NY). 2010;12:439–51.
20. Fenical W. Chemical studies of marine bacteria: developing a new resource.
Chem Rev. 1993;93:1673–83.
21. Lane AL, Moore BS. A sea of biosynthesis: marine natural products meet the
molecular age. Nat Prod Rep. 2011;28:411–28.
22. Wietz M, Mansson M, Vynne NG, Gram L. Small molecule antibiotics from
marine bacteria and strategies to prevent rediscovery of known
compounds. In: Edited by Kim S. Marine microbiology : bioactive
compounds and biotechnological applications. Wiley-VCH Verlag
GmbH & Co. KGaA; 2013. p. 127-59.
23. Wilson MC, Mori T, Rückert C, Uria AR, Helf MJ, Takada K, et al. An
environmental bacterial taxon with a large and distinct metabolic
repertoire. Nature. 2014;506:58–62.
24. Beer LL, Moore BS. Biosynthetic convergence of salinosporamides A and B
in the marine actinomycete Salinispora tropica. Org Lett. 2007;9:845–8.
25. Feling R, Buchanan G. Salinosporamide A: a highly cytotoxic proteasome
inhibitor from a novel microbial source, a marine bacterium of the new
genus Salinospora. Angew Chemie. 2003;42:355–7.
26. Still PC, Johnson TA, Theodore CM, Loveridge ST, Crews P. Scrutinizing the
scaffolds of marine biosynthetics from different source organisms:
Gram-negative cultured bacterial products enter center stage. J Nat Prod.
2014;77:690–702.
27. Månsson M, Phipps RK, Gram L, Munro MHG, Larsen TO, Nielsen KF.
Explorative Solid-Phase Extraction (E-SPE) for accelerated microbial
natural product discovery, dereplication, and purification. J Nat Prod.
2010;73:1126–32.
28. Mansson M, Gram L, Larsen TO. Production of bioactive secondary
metabolites by marine vibrionaceae. Mar Drugs. 2011;9:1440–68.
Machado et al. BMC Genomics  (2015) 16:158 Page 11 of 1229. Wietz M, Mansson M, Gotfredsen CH, Larsen TO, Gram L. Antibacterial
compounds from marine Vibrionaceae isolated on a global expedition.
Mar Drugs. 2010;8:2946–60.
30. Weber T. In silico tools for the analysis of antibiotic biosynthetic pathways.
Int J Med Microbiol. 2014;304:230–5.
31. Fedorova ND, Moktali V, Medema MH. Bioinformatics approaches and
software for detection of secondary metabolic gene clusters. In: Keller NP,
Turner G, editors. Fungal secondary metabolism: methods and protocols.
944th ed. Totowa, NJ: Humana Press; 2012. p. 23–45.
32. Seyedsayamdost MR. High-throughput platform for the discovery of elicitors
of silent bacterial gene clusters. Proc Natl Acad Sci U S A. 2014;111:7266–71.
33. Weber T, Rausch C, Lopez P, Hoof I, Gaykova V, Huson DH, et al. CLUSEAN: a
computer-based framework for the automated analysis of bacterial
secondary metabolite biosynthetic gene clusters. J Biotechnol.
2009;140:13–7.
34. Rausch C, Weber T, Kohlbacher O, Wohlleben W, Huson DH. Specificity
prediction of adenylation domains in Nonribosomal Peptide Synthetases
(NRPS) using Transductive Support Vector Machines (TSVMs). Nucleic Acids
Res. 2005;33:5799–808.
35. Röttig M, Medema MH, Blin K, Weber T, Rausch C, Kohlbacher O.
NRPSpredictor2–a web server for predicting NRPS adenylation domain
specificity. Nucleic Acids Res. 2011;39(Web Server issue):W362–7.
36. Minowa Y, Araki M, Kanehisa M. Comprehensive analysis of distinctive
polyketide and nonribosomal peptide structural motifs encoded in
microbial genomes. J Mol Biol. 2007;368:1500–17.
37. Van Heel AJ, de Jong A, Montalbán-López M, Kok J, Kuipers OP. BAGEL3:
automated identification of genes encoding bacteriocins and (non-)
bactericidal posttranslationally modified peptides. Nucleic Acids Res.
2013;41(Web Server issue):W448–53.
38. Ziemert N, Podell S, Penn K, Badger JH, Allen E, Jensen PR. The natural
product domain seeker NaPDoS: a phylogeny based bioinformatic tool to
classify secondary metabolite gene diversity. PLoS One. 2012;7:e34064.
39. Li MHT, Ung PMU, Zajkowski J, Garneau-Tsodikova S, Sherman DH.
Automated genome mining for natural products. BMC Bioinformatics.
2009;10:185.
40. Mansson M, Nielsen A, Kjærulff L, Gotfredsen CH, Wietz M, Ingmer H, et al.
Inhibition of virulence gene expression in Staphylococcus aureus by novel
depsipeptides from a marine Photobacterium. Mar Drugs. 2011;9:2537–52.
41. Nielsen A, Månsson M, Bojer MS, Gram L, Larsen TO, Novick RP, et al.
Solonamide B inhibits quorum sensing and reduces Staphylococcus aureus
mediated killing of human neutrophils. PLoS One. 2014;9:e84992.
42. Kjaerulff L, Nielsen A, Mansson M, Gram L, Larsen TO, Ingmer H, et al.
Identification of four new agr quorum sensing-interfering
cyclodepsipeptides from a marine Photobacterium. Mar Drugs.
2013;11:5051–62.
43. Nielsen A, Mansson M, Wietz M, Varming AN, Phipps RK, Larsen TO, et al.
Nigribactin, a novel siderophore from Vibrio nigripulchritudo, modulates
Staphylococcus aureus virulence gene expression. Mar Drugs.
2012;10:2584–95.
44. Vynne NG, Månsson M, Nielsen KF, Gram L. Bioactivity, chemical profiling,
and 16S rRNA-based phylogeny of Pseudoalteromonas strains collected on a
global research cruise. Mar Biotechnol (NY). 2011;13:1062–73.
45. Vynne NG, Mansson M, Gram L. Gene sequence based clustering assists in
dereplication of Pseudoalteromonas luteoviolacea strains with identical
inhibitory activity and antibiotic production. Mar Drugs. 2012;10:1729–40.
46. Medema MH, Blin K, Cimermancic P, de Jager V, Zakrzewski P, Fischbach
MA, et al. antiSMASH: rapid identification, annotation and analysis of
secondary metabolite biosynthesis gene clusters in bacterial and fungal
genome sequences. Nucleic Acids Res. 2011;39(Web Server issue):W339–46.
47. Blin K, Medema MH, Kazempour D, Fischbach MA, Breitling R, Takano E,
et al. antiSMASH 2.0–a versatile platform for genome mining of
secondary metabolite producers. Nucleic Acids Res. 2013;41
(Web Server issue):W204–12.
48. Overbeek R, Olson R, Pusch GD, Olsen GJ, Davis JJ, Disz T, et al. The SEED
and the rapid annotation of microbial genomes using Subsystems
Technology (RAST). Nucleic Acids Res. 2014;42(Database issue):D206–14.
49. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, et al. The RAST
Server: rapid annotations using subsystems technology. BMC Genomics.
2008;9:75.
50. Omura S, Ikeda H, Ishikawa J, Hanamoto A, Takahashi C, Shinose M, et al.
Genome sequence of an industrial microorganism Streptomyces avermitilis:deducing the ability of producing secondary metabolites. Proc Natl Acad
Sci U S A. 2001;98:12215–20.
51. Bentley SD, Chater KF, Cerdeño-Tárraga A-M, Challis GL, Thomson NR, James
KD, et al. Complete genome sequence of the model actinomycete
Streptomyces coelicolor A3(2). Nature. 2002;417:141–7.
52. Buchan A, González J, Moran M. Overview of the marine roseobacter
lineage. Appl Environ. 2005;71:5665–77.
53. Wagner-Döbler I, Biebl H. Environmental biology of the marine Roseobacter
lineage. Annu Rev Microbiol. 2006;60:255–80.
54. Porsby CH, Nielsen KF, Gram L. Phaeobacter and Ruegeria species of the
Roseobacter clade colonize separate niches in a Danish Turbot
(Scophthalmus maximus)-rearing farm and antagonize Vibrio anguillarum
under different growth conditions. Appl Environ Microbiol. 2008;74:7356–64.
55. Seyedsayamdost MR, Carr G, Kolter R, Clardy J. Roseobacticides: small
molecule modulators of an algal-bacterial symbiosis. J Am Chem Soc.
2011;133:18343–9.
56. Brinkhoff T, Bach G, Heidorn T, Liang L, Schlingloff A, Simon M. Antibiotic
Production by a Roseobacter Clade-Affiliated Species from the German
Wadden Sea and Its Antagonistic Effects on Indigenous Isolates.
Appl Environ Microbiol. 2004;70:2560–5.
57. Geng H, Bruhn JB, Nielsen KF, Gram L, Belas R. Genetic dissection of
tropodithietic acid biosynthesis by marine roseobacters. Appl Environ
Microbiol. 2008;74:1535–45.
58. Wietz M, Månsson M, Gram L. Chitin stimulates production of the
antibiotic andrimid in a Vibrio coralliilyticus strain. Environ Microbiol Rep.
2011;3:559–64.
59. Jin M, Fischbach MA, Clardy J. A biosynthetic gene cluster for the
acetyl-CoA carboxylase inhibitor andrimid. J Am Chem Soc. 2006;128:10660–1.
60. Gauthier MJ. Morphological, physiological, and biochemical characteristics
of some violet-pigmented bacteria isolated from seawater. Can J Microbiol.
1976;22:138–49.
61. Laatsch H, Pudleiner H. Marine bakterien, I: synthese von
pentabrompseudilin, einem phenylpyrrol aus Alteromonas luteoviolaceus.
Liebigs Ann Chem. 1989;9:863–81.
62. Moore BS. Biosynthesis of marine natural products: macroorganisms (Part B).
Nat Prod Rep. 2006;23:615–29.
63. Conway KR, Boddy CN. ClusterMine360: a database of microbial PKS/NRPS
biosynthesis. Nucleic Acids Res. 2013;41(Database issue):D402–7.
64. Bruhn JB, Nielsen KF, Hjelm M, Hansen M, Bresciani J, Schulz S, et al.
Ecology, inhibitory activity, and morphogenesis of a marine antagonistic
bacterium belonging to the Roseobacter clade. Appl Environ Microbiol.
2005;71:7263–70.
65. Holden MTG, Chhabra SR, De Nys R, Stead P, Bainton NJ, Hill PJ, et al.
Quorum-sensing cross talk: isolation and chemical characterization of cyclic
dipeptides from Pseudomonas aeruginosa and other gram-negative bacteria.
Mol Microbiol. 1999;33:1254–66.
66. Rasmussen BB, Nielsen KF, Machado H, Melchiorsen J, Gram L,
Sonnenschein EC. Global and phylogenetic distribution of quorum sensing
signals, acyl homoserine lactones, in the family of vibrionaceae. Mar Drugs.
2014;12:5527–46.
67. Vynne NG. Bioactivity and phylogeny of the marine bacterial genus
Pseudoalteromonas. Kgs. Lyngby: Technical University of Denmark; 2011.
68. Sandy M, Butler A. Microbial iron acquisition: marine and terrestrial
siderophores. Chem Rev. 2009;109:4580–95.
69. Schwyn B, Neilands JB. Universal chemical assay for the detection and
determination of siderophores. Anal Biochem. 1987;160:47–56.
70. Hider RC, Kong X. Chemistry and biology of siderophores. Nat Prod Rep.
2010;27:637–57.
71. Rudolph G, Hennecke H, Fischer H-M. Beyond the Fur paradigm:
iron-controlled gene expression in rhizobia. FEMS Microbiol Rev.
2006;30:631–48.
72. Williams KP, Gillespie JJ, Sobral BWS, Nordberg EK, Snyder EE, Shallom JM,
et al. Phylogeny of gammaproteobacteria. J Bacteriol. 2010;192:2305–14.
73. Sawabe T, Ogura Y, Matsumura Y, Feng G, Amin AR, Mino S, et al. Updating
the Vibrio clades defined by multilocus sequence phylogeny: proposal of
eight new clades, and the description of Vibrio tritonius sp. nov. Front
Microbiol. 2013;4(December):414.
74. Pascual J, Macián MC, Arahal DR, Garay E, Pujalte MJ. Multilocus
sequence analysis of the central clade of the genus Vibrio by using the 16S
rRNA, recA, pyrH, rpoD, gyrB, rctB and toxR genes. Int J Syst Evol Microbiol.
2010;60(Pt 1):154–65.
Machado et al. BMC Genomics  (2015) 16:158 Page 12 of 1275. Thompson FL, Gevers D, Thompson CC, Dawyndt P, Naser S, Hoste B, et al.
Phylogeny and molecular identification of vibrios on the basis of multilocus
sequence analysis. Appl Environ Microbiol. 2005;71:5107–15.
76. Meibom KL, Li XB, Nielsen AT, Wu C-Y, Roseman S, Schoolnik GK.
The Vibrio cholerae chitin utilization program. Proc Natl Acad Sci U S A.
2004;101:2524–9.
77. Li X, Roseman S. The chitinolytic cascade in Vibrios is regulated by chitin
oligosaccharides and a two-component chitin catabolic sensor/kinase.
Proc Natl Acad Sci U S A. 2004;101:627–31.
78. Frederiksen RF, Paspaliari DK, Larsen T, Storgaard BG, Larsen MH, Ingmer H,
et al. Bacterial chitinases and chitin-binding proteins as virulence factors.
Microbiology. 2013;159(Pt 5):833–47.
79. Souza CP, Almeida BC, Colwell RR, Rivera ING. The importance of chitin in
the marine environment. Mar Biotechnol (NY). 2011;13:823–30.
80. Stauder M, Huq A, Pezzati E, Grim CJ, Ramoino P, Pane L, et al. Role of
GbpA protein, an important virulence-related colonization factor, for Vibrio
cholerae’s survival in the aquatic environment. Environ Microbiol Rep.
2012;4:439–45.
81. Sambrook J, Russel DW. Molecular cloning: a laboratory manual. Cold Spring
Harbour, New York: Cold Spring Harbour Laboratory Press; 2001.
82. Skov MN, Pedersen K, Larsen JL. Comparison of pulsed-field gel
electrophoresis, ribotyping, and plasmid profiling for typing of Vibrio
anguillarum serovar O1. Appl Environ Microbiol. 1995;61:1540–5.
83. Novick R, Morse S. In vivo transmission of drug resistance factors between
strains of Staphylococcus aureus. J Exp Med. 1967;125(1):45–59.
84. Cha C, Gao P, Chen YC, Shaw PD, Farrand SK. Production of
acyl-homoserine lactone quorum-sensing signals by gram-negative
plant-associated bacteria. Mol Plant Microbe Interact. 1998;11:1119–29.
85. Mcclean KH, Winson MK, Fish L, Taylor A, Chhabra SR, Camara M, et al.
Quorum sensing and Chromobacterium violaceum: exploitation of violacein
production and inhibition for the detection of N -acylhomoserine lactones.
1997. p. 3703–11.
86. Ravn L, Christensen AB, Molin S, Givskov M, Gram L. Methods for detecting
acylated homoserine lactones produced by Gram-negative bacteria and
their application in studies of AHL-production kinetics. J Microbiol Methods.
2001;44:239–51.
87. Gram L, Grossart H. Possible quorum sensing in marine snow bacteria:
production of acylated homoserine lactones by Roseobacter strains isolated
from marine snow. Appl. 2002;68:4111–6.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
